These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6333580)

  • 1. [Enhancement by blood transfusions of transplanted tumor growth in mice].
    Kagawa S
    Nihon Geka Gakkai Zasshi; 1984 Jun; 85(6):513-20. PubMed ID: 6333580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on the induction of immunological suppression by blood transfusion].
    Ninomiya M
    Nihon Geka Gakkai Zasshi; 1986 Nov; 87(11):1380-90. PubMed ID: 3491285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of F1 cytotoxic potentials by graft-vs-host reaction. Cooperative non-H-2- and H-2D region-gene control of F1 natural resistance to graft-vs-host reaction-associated immunosuppression.
    Ishikawa H; Saito K; Kubota E
    J Immunol; 1989 Mar; 142(5):1495-9. PubMed ID: 2918225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semi-allogeneic (F1) versus fully allogeneic blood transfusions: differences in their ability to induce specific immunological unresponsiveness.
    Roelen DL; Dover EL; Niimi M; Young NT; Morris PJ; Wood KJ
    Eur J Immunol; 1996 Jul; 26(7):1468-74. PubMed ID: 8766548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of a novel method to induce tolerance in adult mice across fully allogeneic (entire H-2 plus multiminor histocompatibility) antigen barriers, using supralethal irradiation followed by injection of syngeneic bone marrow cells plus (donor X recipient) F1 spleen cells.
    Tomita Y; Himeno K; Mayumi H; Tokuda N; Nomoto K
    Immunobiology; 1989 Jun; 179(2-3):214-29. PubMed ID: 2793203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of blood transfusions from different H-2 donors on immune responses in mice.
    Ludwin D; Singal DP
    Transplantation; 1988 Apr; 45(4):777-83. PubMed ID: 2965836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible induction by blood transfusion of immunological tolerance against growth of transplanted tumors in mice.
    Horimi T; Kagawa S; Ninomiya M; Yoshida E; Hiramatsu S; Orita K
    Acta Med Okayama; 1983 Jun; 37(3):259-63. PubMed ID: 6880833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of graft-versus-host reaction on the immune response to alloantigens and growth of a syngeneic tumor.
    Zaleski M
    Exp Hematol; 1975 Jan; 3(1):12-21. PubMed ID: 238866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-induced tolerance to allografts in mice. X. Augmentation of split tolerance in murine combinations disparate at both H-2 and non-H-2 antigens by the use of spleen cells from donors preimmunized with recipient antigens.
    Mayumi H; Himeno K; Tokuda N; Fan JL; Nomoto K
    Immunobiology; 1987 May; 174(3):274-91. PubMed ID: 3305319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of suppressor T cells in cyclophosphamide-induced tolerance to the non-H-2-encoded alloantigens. Is mixed chimerism really required in maintaining a skin allograft tolerance?
    Tomita Y; Mayumi H; Eto M; Nomoto K
    J Immunol; 1990 Jan; 144(2):463-73. PubMed ID: 2136891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of Mls-reactive T cells in H-2-compatible but Mls-incompatible bone marrow chimeras.
    Yoshikai Y; Ogimoto M; Matsumoto K; Sakumoto M; Matsuzaki G; Nomoto K
    Eur J Immunol; 1989 Jun; 19(6):1009-13. PubMed ID: 2502418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of the timing of blood transfusion on experimental tumor growth.
    Francis DM; Clunie GJ
    J Surg Res; 1993 Mar; 54(3):237-41. PubMed ID: 8474239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfusion-related immunomodulation due to peripheral blood dendritic cells expressing the CD200 tolerance signaling molecule and alloantigen.
    Clark DA; Gorczynski RM; Blajchman MA
    Transfusion; 2008 May; 48(5):814-21. PubMed ID: 18298594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. I. H-2-encoded dominant gene control.
    Green WR
    J Immunol; 1984 May; 132(5):2658-64. PubMed ID: 6425409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific destruction of host-reactive mature T cells of donor origin prevents graft-versus-host disease in cyclophosphamide-induced tolerant mice.
    Eto M; Mayumi H; Tomita Y; Yoshikai Y; Nishimura Y; Maeda T; Ando T; Nomoto K
    J Immunol; 1991 Mar; 146(5):1402-9. PubMed ID: 1671578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-mediated suppression of grafted lymphoma. III. Evaluation of the role of thymic function, non-thymus-derived lymphocytes, macrophages, platelets, and polymorphonuclear leukocytes in syngeneic and allogeneic hosts.
    Shin HS; Hayden M; Langley S; Kaliss N; Smith MR
    J Immunol; 1975 Apr; 114(4):1255-63. PubMed ID: 1078832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-induced tolerance to allografts in mice. IX. Establishment of complete chimerism by allogeneic spleen cell transplantation from donors made tolerant to H-2-identical recipients.
    Mayumi H; Himeno K; Tanaka K; Tokuda N; Fan JL; Nomoto K
    Transplantation; 1986 Oct; 42(4):417-22. PubMed ID: 3532453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of self-reactive T cells in the donor-derived T cells but not in the host-derived T cells in fully allogeneic radiation chimeras. Mls-reactive T cells in allogeneic radiation chimeras.
    Ogimoto M; Yoshikai Y; Matsuzaki G; Ohga S; Matsumoto K; Nomoto K
    Thymus; 1991 Feb; 17(1):11-22. PubMed ID: 1901675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of F1 cytotoxic potentials by GvHR: role and mode of action of non-MHC genes that determine the hybrid resistance to GvHR-associated suppression of F1 cytotoxic potential.
    Ishikawa H; Kubota E; Saito K
    J Immunol; 1984 May; 132(5):2218-25. PubMed ID: 6232314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical evidence for expression of a semi-allogeneic, H-2 antigen by a murine adenocarcinoma.
    Callahan GN; Pardi D; Giedlin MA; Allison JP; Morizot DM; Martin WJ
    J Immunol; 1983 Jan; 130(1):471-9. PubMed ID: 6847892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.